Mycronic AB (publ) (STO:MYCR)
Sweden · Delayed Price · Currency is SEK 342.80
-4.80 (-1.38%)
Jul 24, 2026, 5:29 PM CET
Mycronic AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 8,649 | 7,938 | 7,057 | 5,706 | 5,119 | 4,635 | |
Revenue Growth (YoY) | 7.48% | 12.48% | 23.68% | 11.47% | 10.44% | 19.40% |
Cost of Revenue | 4,007 | 3,775 | 3,338 | 2,850 | 2,831 | 2,351 |
Gross Profit | 4,640 | 4,163 | 3,719 | 2,855 | 2,288 | 2,284 |
Selling, General & Admin | 1,328 | 1,205 | 989 | 996 | 889 | 769 |
Research & Development | 1,102 | 978 | 747 | 653 | 638 | 548 |
Other Operating Expenses | -21 | 40 | -37 | -28 | -133 | -82 |
Total Operating Expenses | 2,409 | 2,223 | 1,699 | 1,621 | 1,394 | 1,235 |
Operating Income | 2,233 | 1,940 | 2,021 | 1,235 | 894 | 1,049 |
Interest Income | - | 46 | 78 | 40 | 9 | 11 |
Interest Expense | - | -17 | -15 | -13 | -13 | -14 |
Other Non-Operating Income (Expense) | -12 | 30 | 63 | 27 | -4 | -2 |
Total Non-Operating Income (Expense) | -12 | 59 | 126 | 54 | -8 | -5 |
Pretax Income | 2,220 | 1,970 | 2,084 | 1,262 | 890 | 1,046 |
Provision for Income Taxes | 486 | 410 | 396 | 266 | 154 | 219 |
Net Income | 1,735 | 1,560 | 1,688 | 996 | 737 | 827 |
Minority Interest in Earnings | -1 | 0 | 5 | -2 | -4 | -1 |
Net Income to Common | 1,736 | 1,560 | 1,683 | 998 | 741 | 828 |
Net Income Growth | -12.06% | -7.31% | 68.64% | 34.68% | -10.51% | 19.31% |
Shares Outstanding (Basic) | 195 | 195 | 195 | 195 | 195 | 195 |
Shares Outstanding (Diluted) | 195 | 195 | 195 | 195 | 195 | 195 |
Shares Change (YoY) | 0.01% | -0.00% | 0.01% | 0.03% | -0.10% | -0.06% |
EPS (Basic) | 8.88 | 7.99 | 8.62 | 5.11 | 3.79 | 4.24 |
EPS (Diluted) | 8.88 | 7.99 | 8.62 | 5.11 | 3.79 | 4.24 |
EPS Growth | -12.17% | -7.31% | 68.69% | 34.65% | -10.50% | 19.44% |
Free Cash Flow | 2,050 | 1,316 | 1,748 | 1,505 | 746 | 956 |
Free Cash Flow Growth | 44.27% | -24.71% | 16.15% | 101.74% | -21.97% | -11.64% |
Free Cash Flow Per Share | 10.50 | 6.74 | 8.95 | 7.71 | 3.82 | 4.89 |
Dividends Per Share | 3.250 | 3.250 | 2.750 | 2.250 | 1.750 | 1.500 |
Dividend Growth | 18.18% | 18.18% | 22.22% | 28.57% | 16.67% | 0% |
Gross Margin | 53.65% | 52.44% | 52.70% | 50.04% | 44.70% | 49.28% |
Operating Margin | 25.82% | 24.44% | 28.64% | 21.64% | 17.46% | 22.63% |
Profit Margin | 20.06% | 19.65% | 23.92% | 17.46% | 14.40% | 17.84% |
FCF Margin | 23.70% | 16.58% | 24.77% | 26.38% | 14.57% | 20.63% |
EBITDA | 2,233 | 2,270 | 2,287 | 1,499 | 1,147 | 1,254 |
EBITDA Margin | 25.82% | 28.60% | 32.41% | 26.27% | 22.41% | 27.05% |
EBIT | 2,233 | 1,940 | 2,021 | 1,235 | 894 | 1,049 |
EBIT Margin | 25.82% | 24.44% | 28.64% | 21.64% | 17.46% | 22.63% |
Effective Tax Rate | 21.89% | 20.81% | 19.00% | 21.08% | 17.30% | 20.94% |